|
🐜
|
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
17 auth.
G. Demetri,
A. Oosterom,
C. Garrett,
M. Blackstein,
M. Shah,
J. Verweij,
G. McArthur,
I. Judson,
M. Heinrich,
J. Morgan,
...
J. Desai,
C. Fletcher,
S. George,
C. Bello,
Xin Huang,
C. Baum,
P. Casali
|
11 |
2006 |
11
🐜
|
|
🐜
|
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
15 auth.
R. DeMatteo,
K. Ballman,
C. Antonescu,
R. Maki,
P. Pisters,
G. Demetri,
M. Blackstein,
C. Blanke,
M. Mehren,
M. Brennan,
...
Shreyaskumar R Patel,
M. McCarter,
J. Polikoff,
B. Tan,
K. Owzar
|
10 |
2009 |
10
🐜
|
|
🐜
|
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
24 auth.
G. Demetri,
P. Reichardt,
Yoon-Koo Kang,
J. Blay,
P. Rutkowski,
H. Gelderblom,
P. Hohenberger,
M. Leahy,
M. Mehren,
H. Joensuu,
...
G. Badalamenti,
M. Blackstein,
A. Cesne,
P. Schöffski,
R. Maki,
S. Bauer,
B. Nguyen,
Jianming Xu,
T. Nishida,
J. Chung,
C. Kappeler,
I. Kuss,
D. Laurent,
P. Casali
|
10 |
2013 |
10
🐜
|
|
🐜
|
neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group.
23 auth.
I. Andrulis,
S. Bull,
M. Blackstein,
D. Sutherland,
C. Mak,
S. Sidlofsky,
K. Pritzker,
R. Hartwick,
W. Hanna,
L. Lickley,
...
R. Wilkinson,
A. Qizilbash,
U. Ambus,
M. Lipa,
H. Weizel,
A. Katz,
M. Baida,
S. Mariz,
G. Stoik,
P. Dacamara,
D. Strongitharm,
W. Geddie,
D. McCready
|
8 |
1998 |
8
🐜
|
|
🐜
|
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.
15 auth.
C. Corless,
K. Ballman,
C. Antonescu,
V. Kolesnikova,
R. Maki,
P. Pisters,
M. Blackstein,
C. Blanke,
G. Demetri,
M. Heinrich,
...
M. von Mehren,
Shreyaskumar R Patel,
M. McCarter,
K. Owzar,
R. DeMatteo
|
8 |
2014 |
8
🐜
|
|
🐜
|
Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial.
10 auth.
R. Burkes,
R. Ginsberg,
F. Shepherd,
M. Blackstein,
M. Goldberg,
P. Waters,
...
G. Patterson,
T. Todd,
F. Pearson,
J. Cooper
|
7 |
1992 |
7
🐜
|
|
🐢
|
Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases.
A. Aljubran,
A. Griffin,
M. Pintilie,
M. Blackstein
|
7 |
2009 |
7
🐢
|
|
🦁
|
Gemcitabine as First-Line Therapy in Patients with Metastatic Breast Cancer: A Phase II Trial
M. Blackstein,
C. Vogel,
R. Ambinder,
J. Cowan,
J. Iglesias,
A. Melemed
|
7 |
2002 |
7
🦁
|
|
🐜
|
Lymph Node Metastasis in Soft Tissue Sarcoma in an Extremity
11 auth.
S. Riad,
A. Griffin,
B. Liberman,
M. Blackstein,
C. Catton,
R. Kandel,
...
B. O'Sullivan,
L. White,
R. Bell,
P. Ferguson,
J. Wunder
|
7 |
2004 |
7
🐜
|
|
🐜
|
Histologic assessment of peritumoral edema in soft tissue sarcoma.
8 auth.
L. White,
J. Wunder,
R. Bell,
B. O'Sullivan,
C. Catton,
P. Ferguson,
...
M. Blackstein,
R. Kandel
|
7 |
2005 |
7
🐜
|
|
🐜
|
Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment.
8 auth.
M. Blackstein,
J. Blay,
C. Corless,
D. Driman,
R. Riddell,
D. Soulières,
...
C. Swallow,
S. Verma
|
7 |
2006 |
7
🐜
|
|
🐜
|
Phase 3, multicenter, randomized, double-blind, placebo-controlled trial of SU11248 in patients (pts) following failure of imatinib for metastatic GIST
10 auth.
G. Demetri,
A. Oosterom,
M. Blackstein,
C. Garrett,
M. Shah,
M. Heinrich,
...
G. McArthur,
I. Judson,
C. Baum,
P. Casali
|
7 |
2005 |
7
🐜
|
